
New features in the classification of patients with myelodysplastic disease
11.06.2022
Researchers from the Veneto Institute of Molecular Medicine (VIMM) and the University of Padua focused on hypocellular myelodysplastic syndromes (h-MDS) that represent a rare subgroup of MDS. They thus identified the clinical features and molecular markers associated with a longer life expectancy in patients with this disease.